NUVAMA - Investment Analysis: Buy Signal or Bull Trap?
Last Updated Time : 20 Dec 25, 07:10 am
Back to Investment ListInvestment Rating: 3.7
| Stock Code | NUVAMA | Market Cap | 26,096 Cr. | Current Price | 7,177 ₹ | High / Low | 8,510 ₹ |
| Stock P/E | 52.0 | Book Value | 550 ₹ | Dividend Yield | 2.02 % | ROCE | 30.6 % |
| ROE | 32.6 % | Face Value | 10.0 ₹ | DMA 50 | 7,155 ₹ | DMA 200 | 6,807 ₹ |
| Chg in FII Hold | -0.84 % | Chg in DII Hold | 1.24 % | PAT Qtr | 46.4 Cr. | PAT Prev Qtr | 221 Cr. |
| RSI | 53.8 | MACD | 6.58 | Volume | 3,44,360 | Avg Vol 1Wk | 1,18,973 |
| Low price | 4,568 ₹ | High price | 8,510 ₹ | PEG Ratio | 0.36 | Debt to equity | 0.19 |
| 52w Index | 66.2 % | Qtr Profit Var | -85.4 % | EPS | 140 ₹ | Industry PE | 20.7 |
📊 NUVAMA shows strong efficiency metrics with ROE (32.6%) and ROCE (30.6%), supported by a healthy dividend yield (2.02%) and low debt-to-equity (0.19). EPS (₹140) is robust, and PEG ratio (0.36) suggests undervaluation relative to growth. However, the stock trades at a high P/E (52.0) compared to the industry average (20.7), and quarterly profit dropped sharply (-85.4%), raising concerns about earnings stability. Overall, NUVAMA is a promising candidate for long-term investment but requires cautious entry due to volatility in profits.
💡 Ideal Entry Price Zone: Accumulation is favorable in the 6,700–7,000 ₹ range, closer to DMA 200 support, for long-term investors.
⏳ Exit Strategy / Holding Period: If already holding, investors should maintain positions for the medium to long term (3–5 years), given strong ROE/ROCE and dividend yield. Partial profit booking can be considered near 8,200–8,500 ₹ if valuations stretch without proportional earnings recovery.
✅ Positive
- 📈 Strong ROE (32.6%) and ROCE (30.6%) reflect efficient capital usage.
- 💰 Dividend yield of 2.02% provides steady income.
- 📊 EPS of ₹140 highlights strong earnings visibility.
- 📉 Debt-to-equity ratio of 0.19 indicates low leverage.
- 📊 PEG ratio of 0.36 suggests undervaluation relative to growth potential.
⚠️ Limitation
- ❌ High P/E (52.0) compared to industry average (20.7).
- ❌ Sharp decline in quarterly PAT (-85.4%) raises concerns about earnings stability.
- ❌ Book value (₹550) is far below current price, showing premium valuation.
- ❌ RSI at 53.8 indicates neutral momentum, limiting immediate upside.
📉 Company Negative News
- ❌ Quarterly PAT dropped significantly to ₹46.4 Cr. from ₹221 Cr.
- ❌ FII holdings decreased (-0.84%), showing reduced foreign investor confidence.
📈 Company Positive News
- ✅ DII holdings increased (+1.24%), showing strong domestic institutional support.
- ✅ Dividend yield supports long-term investor confidence.
- ✅ Stock has delivered strong 52-week performance (+66.2%).
🏭 Industry
- 📊 Industry PE is 20.7, much lower than NUVAMA’s 52.0, suggesting premium valuations.
- ⚡ Financial services sector remains a structural growth story, supported by rising retail and institutional participation.
🔎 Conclusion
✅ NUVAMA is a good candidate for long-term investment with strong ROE/ROCE, dividend yield, and low debt. However, earnings volatility and high valuations require cautious entry. Ideal entry is near 6,700–7,000 ₹, with a long-term holding horizon of 3–5 years. Partial exits can be considered near 8,200–8,500 ₹ if valuations stretch without significant improvement in profitability.
Back to Investment ListNIFTY 50 - Today Top Investment Picks Stock Picks
NEXT 50 - Today Top Investment Picks Stock Picks
MIDCAP - Today Top Investment Picks Stock Picks
SMALLCAP - Today Top Investment Picks Stock Picks